H-Index
34
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST

Logo

MSMbanner
Medical Science Monitor Basic Research

AmJCaseRep
MedSciTechnol

eISSN: 2329-0358

Liver transplantation in patients with hepatocellular carcinoma

Wojciech G. Polak, Akihiko Soyama, Maarten J.H. Slooff

Ann Transplant 2008; 13(4): 5-15

ID: 880212

Available online:

Published:


Liver transplantation has a definitive place in the treatment of patients with  hepatocellular carcinoma (HCC) in a cirrhotic liver. Patients with a tumor load within the Milan criteria have excellent survival comparable to survival in patients with benign indications. When tumor load exceeds the Milan criteria survival decreases. Staging of patients with HCC in a cirrhotic liver is deficient due to the restrictions of the current imaging modalities. The exact place of tumor controlling therapies during the waiting time for transplantation is not yet clear. No evidence of sufficient level is available as to the efficacy of pre-, per- or postoperative chemotherapy. Promising new drugs are currently tested. This counts also for the use of new immunosuppressant with concomitant tumor suppressive capabilities.

Keywords: Liver Transplantation, hepatocellular carcinoma, Outcome, Surgery, transarterial chemoembolization, RADIO FREQUENCY ABLATION, percutaneous ethanol injection



Back